Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • US

    Tag: us

    You Searched For "US"
    Lupin gets tentative USFDA nod for generic version of Mirabegron ER tablets

    Lupin gets tentative USFDA nod for generic version of Mirabegron ER tablets

    Farhat Nasim28 Jun 2019 11:10 AM IST
    The approval by the US Food and Drug Administration (USFDA) is for a generic version of Mirabegron ER tablets of strengths 25 mg and 50 mg, Lupin said...
    Dr Reddys launches generic version of Tobi in US market

    Dr Reddys launches generic version of Tobi in US market

    Farhat Nasim26 Jun 2019 3:07 PM IST
    The product is a therapeutic equivalent generic version of TOBI (tobramycin) Inhalation Solution, approved by the U.S. Food and Drug Administration...
    Novartis

    Novartis' secret settlement talks revealed in accidental filing: Bloomberg Report

    Medical Dialogues Bureau13 Jun 2019 10:03 AM IST
    The U.S. sued the Novartis six years ago, joining in a case filed by a former sales representative who accused the company of using its speaker's...
    Roche, Spark Therapeutics $4.3 billion deal delayed again amid US, UK scrutiny

    Roche, Spark Therapeutics $4.3 billion deal delayed again amid US, UK scrutiny

    Farhat Nasim10 Jun 2019 9:30 AM IST
    Roche said on Monday that both companies received a request for more information from the U.S. Federal Trade Commission in connection with the FTC's...
    Roche, GE Healthcare launch NAVIFY Tumor Board to enable personalised treatment decisions in cancer care

    Roche, GE Healthcare launch NAVIFY Tumor Board to enable personalised treatment decisions in cancer care

    Medical Dialogues Bureau3 Jun 2019 9:45 AM IST
    The new version of NAVIFY Tumor Board is initially available in the United States and Canada with additional markets to follow in the near future.New...
    Pfizer epilepsy drug Lyrica fails in phase III trial

    Pfizer epilepsy drug Lyrica fails in phase III trial

    Medical Dialogues Bureau28 May 2019 9:00 AM IST
    New Delhi: Pfizer Inc. recently announced that a Phase 3 study to assess the use of LYRICA (pregabalin) as adjunctive therapy for epilepsy patients 5...
    GSK reintroduce incentives for sales representatives

    GSK reintroduce incentives for sales representatives

    Farhat Nasim24 May 2019 9:31 AM IST
    GSK said it would make changes to its incentive program for pharmaceutical and vaccines sales representatives, to be applied initially in the United...
    Panacea Biotec gets USFDA nod for chemotherapy drug Azacitidine

    Panacea Biotec gets USFDA nod for chemotherapy drug Azacitidine

    Farhat Nasim22 May 2019 9:45 AM IST
    Azacitidine is a chemotherapy drug used to treat myelodysplastic syndromes (MDS) with annual sales of about USD 110 million in US markets as per IQVIA...
    Lupin, Zydus Cadila recall products in US; includes BP drug Carvedilol

    Lupin, Zydus Cadila recall products in US; includes BP drug Carvedilol

    Farhat Nasim6 May 2019 10:00 AM IST
    Lupin Somerset is recalling 46,700 bottles of Morphine Sulfate extended-release tablets in various strengths due to "failed impurities/degradation...
    China war on healthcare costs lure Indian drugmaker Sun Pharma: Report

    China war on healthcare costs lure Indian drugmaker Sun Pharma: Report

    Medical Dialogues Bureau6 May 2019 9:15 AM IST
    China has rolled out an ambitious multi-city bulk procurement program that's driving down prices and providing an opening for Indian manufacturers...
    Sanofi wins USFDA approval to sell dengue vaccine Dengvaxia in parts of US

    Sanofi wins USFDA approval to sell dengue vaccine Dengvaxia in parts of US

    Farhat Nasim2 May 2019 10:00 AM IST
    Dengvaxia is a live, attenuated vaccine that is administered as three separate injections, with the initial dose followed by two additional shots...
    Zydus Cadila gets USFDA nod to market 2 generic drugs

    Zydus Cadila gets USFDA nod to market 2 generic drugs

    Medical Dialogues Bureau1 May 2019 8:05 PM IST
    New Delhi: Drug firm Zydus Cadila Tuesday said it has received the final nod from the USFDA to market generic Bosentan tablets and Trientine...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok